WealthTrust Fairport’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$75K Buy
396
+30
+8% +$5.73K 0.01% 213
2018
Q4
$71K Sell
366
-85
-19% -$16.6K 0.01% 206
2018
Q3
$93K Hold
451
0.01% 208
2018
Q2
$83K Sell
451
-258
-36% -$45.6K 0.01% 213
2018
Q1
$121K Buy
+709
New +$130K 0.01% 176
2015
Q1
Sell
-308
Closed -$49K 147
2014
Q4
$49K Hold
308
0.01% 177
2014
Q3
$43K Hold
308
0.01% 164
2014
Q2
$36K Buy
308
+300
+3,750% +$34.7K 0.01% 170
2014
Q1
$1K Buy
+8
New +$970 ﹤0.01% 263
2013
Q4
Sell
-15
Closed -$2K 293
2013
Q3
$2K Buy
+15
New +$1.63K ﹤0.01% 382

Other funds holding AMGN

WealthTrust Fairport's AMGN Position: Q1 2019 in Review

WealthTrust Fairport increased its Amgen (AMGN) stake by 8.2% in Q1 2019, buying an estimated $5.73K and bringing the position to 396 shares worth $75K. The position accounts for 0.01% of the portfolio, ranked #213.

WealthTrust Fairport first reported a position in AMGN in Q3 2013 and has held it in 10 quarters since. The position peaked at $121K in Q1 2018. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • WealthTrust Fairport held 396 shares of Amgen worth $75K as of Q1 2019.
  • WealthTrust Fairport bought 30 Amgen shares in Q1 2019, an estimated $5.73K.
  • Amgen made up 0.01% of WealthTrust Fairport's portfolio in Q1 2019, its #213 holding.
  • WealthTrust Fairport first reported a position in Amgen in Q3 2013 and has held it in 10 quarters since.
  • WealthTrust Fairport's Amgen position peaked at $121K in Q1 2018.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on WealthTrust Fairport's 13F filing for Q1 2019, filed 15 May 2019.